Acute treatment of migraine: quantifying the unmet need through real-world data in Italy.

ABSTRACT:

Objective

This study is describing subjects with migraine interrupting or not receiving triptans for acute treatment and providing a national-level estimate of people who might benefit from different therapeutic approaches.

Methods

This is a retrospective analysis using IQVIA Longitudinal Patient Database. Starting from 18 + years old individuals with migraine, we selected two cohorts: subjects with triptans prescriptions before and no triptans prescriptions after Index Date (triptan withdraw) and subjects without triptans prescriptions both before and after Index Date (no triptan prescriptions). Index Date was the first record of a health encounter for migraine in 2019. Individuals with cardiovascular disease (CVD) within no triptan prescriptions group were also quantified.

SUBMITTER: Sacco S 

PROVIDER: S-EPMC11306385 | biostudies-literature | 2024 Sep

REPOSITORIES: biostudies-literature